Chemoinformaics analysis of 8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate
| Molecular Weight | 277.32 | nRot | 3 |
| Heavy Atom Molecular Weight | 258.168 | nRig | 16 |
| Exact Molecular Weight | 277.131 | nRing | 3 |
| Solubility: LogS | -2.268 | nHRing | 2 |
| Solubility: LogP | 1.847 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 42.0271 |
| nHD | 2 | BPOL | 23.9709 |
| QED | 0.825 |
| Synth | 3.824 |
| Natural Product Likeliness | 1.101 |
| NR-PPAR-gamma | 0.379 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.299 |
| HIA | 0.035 |
| CACO-2 | -4.669 |
| MDCK | 0.0000108 |
| BBB | 0.084 |
| PPB | 0.336527 |
| VDSS | 3.809 |
| FU | 0.585144 |
| CYP1A2-inh | 0.23 |
| CYP1A2-sub | 0.821 |
| CYP2c19-inh | 0.396 |
| CYP2c19-sub | 0.258 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.622 |
| CYP2d6-inh | 0.507 |
| CYP2d6-sub | 0.827 |
| CYP3a4-inh | 0.106 |
| CYP3a4-sub | 0.269 |
| CL | 11.323 |
| T12 | 0.799 |
| hERG | 0.667 |
| Ames | 0.041 |
| ROA | 0.053 |
| SkinSen | 0.396 |
| Carcinogencity | 0.144 |
| EI | 0.019 |
| Respiratory | 0.885 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.821627 |